Roche Holding | ROG - Selling And Administration Expenses

Stock Price
369.10
Daily Change
1.30 0.35%
Monthly
5.31%
Yearly
23.82%
Q1 Forecast
358.86

Roche Holding reported CHF7.28B in Selling and Administration Expenses for its fiscal semester ending in December of 2025.





Selling And Administration Expenses Change Date
AbbVie USD 3.89B 325M Dec/2025
Alcon AG USD 865M 5M Sep/2025
Amgen USD 1.94B 237M Dec/2025
AstraZeneca USD 4.61B 4.46B Dec/2025
Bayer EUR 3.4B 140M Sep/2025
Biogen USD 545.2M 38.6M Sep/2025
Bristol-Myers Squibb USD 2.18B 392M Dec/2025
Eli Lilly USD 3.13B 391.3M Dec/2025
Fresenius EUR 676M 64M Sep/2025
Fresenius Medical Care EUR 705.44M 86.56M Sep/2025
Galapagos EUR 34.55M 3.88M Sep/2025
Genmab DKK 144M 18M Jun/2025
Gilead Sciences USD 1.78B 425M Dec/2025
GlaxoSmithKline GBP 2.68B 518M Dec/2025
GRIFOLS EUR 284.99M 2.24M Sep/2025
Hikma Pharmaceutical USD 139M 149M Jun/2025
Merck EUR 1.46B 16M Sep/2025
Merck USD 2.85B 215M Dec/2025
Novartis USD 3.31B 134M Sep/2025
Orion EUR 110.7M 26.1M Dec/2025
Pfizer USD 4.08B 894M Dec/2025
Philips EUR 1.31B 127M Dec/2025
Recordati EUR 171.38M 15.6M Sep/2025
Regeneron Pharmaceuticals USD 775M 117.2M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
UCB EUR 1.29B 221M Dec/2024